Ciccio John 4

What Happened
John Ciccio, a director of OS Therapies, was granted options to purchase 50,000 shares of the company’s common stock on January 22, 2026. The Form 4 records the award as a derivative acquisition of 50,000 shares at $0.00 (total $0) — this reflects an option grant, not an immediate issuance of common stock or a cash purchase.

Key Details

• Transaction date: January 22, 2026; Filing date: February 13, 2026 (appears to be a late filing).
• Transaction type: Award/Grant of options (code A, derivative).
• Amount: Options to purchase 50,000 shares; reported acquisition value $0.00 on the Form 4.
• Vesting: Options vest in full on the one‑year anniversary of the grant (Jan 22, 2027) provided Ciccio is serving as a director on that date (per footnote).
• Ownership / control: Footnote notes Ciccio serves on the board of managers of Mill River Partners LLC and shares voting and investment power with respect to these shares.
• Shares owned after transaction: Not specified in the filing.

Context
This was an option grant (an award), not an immediate purchase or sale of shares. The options must vest before Ciccio can exercise them; the filing does not show an exercise, sale, or cashless transaction. Award grants are commonly used for director compensation and do not by themselves indicate a buy or sell sentiment until exercised or sold. The filing delay (filed ~3 weeks after the grant) is noted — late reports can be corrected or explained in amendments.